Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
TSTL

Tristel plc

TSTLLSEUnited KingdomHealthcareMedical Instruments & SuppliesFTSE AIM 100

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.…more

P/E23.07xP/B5.27xROIC26.2%Dividend yield3.7%
£188.55M
Market Cap
EV: £179.44M
MOM6
QUAL10
VAL5
RSK3
TSTL
£188.55M
Market Cap · EV £179.44M

Tristel plc

MOM6
QUAL10
VAL5
RSK3

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.…more

Latest RNS from Tristel plc

Analyst consensus: Buy

As of 10 Nov 2026, 6 analysts rate Tristel plc a Buy, with 67% buy ratings and a mean price target of 471p (range 400p–560p), +20% vs the current price.

Strong buy: 0Buy: 4Hold: 2Sell: 0Strong sell: 0

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 244p against a current price of 394p (-38%), based on EV/EBITDA.

More Healthcare companies